The FDA on Thursday approved Bristol Myers Squibb’s new schizophrenia drug in one of the year’s most anticipated regulatory decisions.
The approval gives Bristol Myers …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
An FDA advisory committee on Monday unanimously supported the investigational drug donanemab for treating early Alzheimer’s disease. In an 11-0 vote, the Peripheral and Central
In a paper titled, “Multimodal MRI reveals brainstem connections that sustain wakefulness in human consciousness,” published today in Science Translational Medicine, a group of researchers
A total of eight retinal vasculitis, an inflammation of blood vessels in the retina of the eye, events have been reported since April 2023. Image